checkAd
    Startseite > Aktien > BioStem Technologies > Nachrichten
    BioStem Technologies Aktie
    7,4100
     
    USD
    +0,14 %
    +0,0100 USD
    Letzter Kurs 17:40:33 Nasdaq OTC
    ISIN: US0906842002 · WKN: A14M3B · SYM: BSEM · USA

    Neueste Nachrichten

    BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million
    14.05.24 · globenewswire · BioStem Technologies
    BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
    07.05.24 · globenewswire · BioStem Technologies
    BioStem Technologies Granted Prioritized Examination for Wound Healing Patent
    06.05.24 · globenewswire · BioStem Technologies
    BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts
    30.04.24 · globenewswire · BioStem Technologies
    BioStem Technologies to Present at the 2024 Planet MicroCap Showcase
    25.04.24 · globenewswire · BioStem Technologies
    BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange
    24.04.24 · globenewswire · BioStem Technologies
    BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference
    02.04.24 · globenewswire · BioStem Technologies
    BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase
    01.04.24 · globenewswire · BioStem Technologies
    BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024
    21.03.24 · globenewswire · BioStem Technologies
    Amniowrap2 Product Launch Leads Year of Highlights for BioStem Technologies
    30.01.24 · globenewswire · BioStem Technologies
    BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer Role
    11.01.24 · globenewswire · BioStem Technologies
    BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
    19.12.23 · globenewswire · BioStem Technologies